Clinical benefits for Remote Monitoring

For cardiac device patients, there is comfort knowing a medical professional is keeping an eye on your device. There are vast amounts of evidence that highlight the benefits of using remote monitoring, including a peace of mind that any abnormalities or events can be addressed as quickly as possible (automatically, rhythm changes, system alerts etc.). Remote monitoring also allows you, the patient, increased engagement in your own healthcare.

Clinical utilization of remote monitoring has been extensively reviewed by the Australian Government and has been provided its own Medicare Benefit Schedule. The Heart Rhythm Society (HRS) recommends remote monitoring as the standard of care for all cardiac device patients. This is why Qardia offers this service 24 hours a day, 7 days a week.

Proven benefits of remote monitoring include:

SVG
Clinical benefits   Safety and efficacy
SAFETY AND EFFICACY
  • Safe extension of face to face encounters. 1
  • Effectively substituted for in-clinic visits. 2
SVG
Clinical benefits   Detection of clinical events
DETECTION OF CLINICAL EVENTS
  • Median time to clinical decision reduced from 22 to 4.6 days. 2
  • Quicker detection of clinical events. 3
  • 43% of patients with implantable devices will have cardiac arrhythmias (atrial fibrillation). These arrhythmias can increase the risk of stroke. 4
SVG
Clinical benefits   Social
SOCIAL
  • Significant reduction in the annual cost for patients. 5
  • Increased quality of life. 5
SVG
Clinical benefits   Survival
SURVIVAL
  • Reduced total healthcare visits by 21% for heart failure, arrhythmia, or ICD related events. 5
  • Higher 1-year and 5-year survival rates. 6
  • Reduced death by 50%. 6
  • Benefits dependent on frequency/adherence to remote monitoring. 7
  • Reduction in appropriate and inappropriate shocks. 8
  1. Varma, N., Epstein, A., Irimpen, A., Schweikert, R. and Love, C. (2010). Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up. Circulation, 122(4), pp.325-332.
  2. Crossley, G., Boyle, A., Vitense, H., Sherfesee, L. and Mead, R. (2008). Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: The Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study. American Heart Journal, 156(5), pp.840-846.
  3. Chen J, Wilkoff BL, Choucair W, et al Design of the Pacemaker Remote Follow-up Evaluation and Review (PREFER) trial to assess the clinical value of the remote pacemaker interrogation in the management of pacemaker patients. http://www.trialsjournal.com/content/9/1/18. April 3, 2008.
  4. Boriani, G., Glotzer, T., Santini, M., West, T., De Melis, M., Sepsi, M., Gasparini, M., Lewalter, T., Camm, J. and Singer, D., 2013. Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). European Heart Journal, 35(8), pp.508-516.
  5. Landolina, M., Perego, G., Lunati, M., Curnis, A., Guenzati, G., Vicentini, A., Parati, G., Borghi, G., Zanaboni, P., Valsecchi, S. and Marzegalli, M. (2012). Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators. Circulation, 125(24), pp.2985-2992.
  6. Saxon, L., Hayes, D., Gilliam, F., Heidenreich, P., Day, J., Seth, M., Meyer, T., Jones, P. and Boehmer, J. (2010). Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up. Circulation, 122(23), pp.2359-2367.
  7. Varma, N., Piccini, J., Snell, J., Fischer, A., Dalal, N. and Mittal, S. (2015). The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. Journal of the American College of Cardiology, 65(24), pp.2601-2610.
  8. Guedon-Moreau, L., Lacroix, D., Sadoul, N., Clementy, J., Kouakam, C., Hermida, J., Aliot, E., Boursier, M., Bizeau, O. and Kacet, S. (2012). A randomized study of remote follow-up of implantable cardioverter defibrillators: safety
  9. Campbell K (2019). Automation of Remote Monitoring of Cardiac Implantable Electronic Devices (CIED’s): The Clinical Implications of After-Hours Data Management. Scientific Poster. Asia Pacific Heart Rhythm Meeting, Bangkok.